Right- and left-sided colorectal cancers respond differently to cetuximab

INTRODUCTION: Right-sided colon cancer (RSCC) and left-sided colorectal cancer (LSCRC) differ with respect to their biology and genomic patterns. This study aimed to examine whether the primary tumor location is associated with the response to cetuximab in patients with metastatic colorectal cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Feng, Bai, Long, Liu, Tian-Shu, Yu, Yi-Yi, He, Ming-Ming, Liu, Kai-Yan, Luo, Hui-Yan, Zhang, Dong-Sheng, Jin, Yin, Wang, Feng-Hua, Wang, Zhi-Qiang, Wang, De-Shen, Qiu, Miao-Zhen, Ren, Chao, Li, Yu-Hong, Xu, Rui-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593341/
https://www.ncbi.nlm.nih.gov/pubmed/26111811
http://dx.doi.org/10.1186/s40880-015-0022-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593341/
https://www.ncbi.nlm.nih.gov/pubmed/26111811
http://dx.doi.org/10.1186/s40880-015-0022-x

Ejemplares similares